Recent Finacing
Recent Raise
Zhangjiang, Shanghai-based Abbisko Therapeutics develops small-molecule immuno-oncology drugs for cancers prevalent in Asian populations, with three preclinical programs led by ABSK001 (in lead optimization) and early-stage noncancer programs.
